• Citer

Circulating tumor cells (CTCs) monitoring in HER2-negative early breast cancer: Implications for secondary anti-HER2 adjuvant treatment strategies

par Ignatiadis, Michail ;Perraki, Maria;Apostolaki, Stella;Xenidis, Nikos;Stathopoulos, Efstathios N;Lianidou, Evi;Buyse, Marc;Sotiriou, Christos ;Georgoulias, Vassilis;Mavroudis, Dimitris
Référence 2008 ASCO Annual Meeting(May 30-June 2, 2008: Chicago, IL, USA), Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition), Vol. Vol 26, No 15S
Publication Publié, 2008-05

Abstract de conférence

• Détails
• Contenu

Titre:	Circulating tumor cells (CTCs) monitoring in HER2-negative early breast cancer: Implications for secondary anti-HER2 adjuvant treatment strategies
Auteur:	Ignatiadis, Michail; Perraki, Maria; Apostolaki, Stella; Xenidis, Nikos; Stathopoulos, Efstathios N; Lianidou, Evi; Buyse, Marc; Sotiriou, Christos; Georgoulias, Vassilis; Mavroudis, Dimitris
Informations sur la publication:	2008 ASCO Annual Meeting(May 30-June 2, 2008: Chicago, IL, USA), Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition), Vol. Vol 26, No 15S
Statut de publication:	Publié, 2008-05
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
Langue:	Anglais